Fibrocor Therapeutics L.P.
Industry
- Biotechnology
- Large Molecule
- Antibodies
- Large Molecule
- Pharmaceuticals
Latest on Fibrocor Therapeutics L.P.
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biogen’s Pact With AbCellera Will Focus
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Novo/Fauna Partnership Inclu
Bridge Biotherapeutics Inc. has reached a global licensing out and collaboration agreement with Boehringer Ingelheim GmbH for the South Korean biotech’s early clinical stage molecule BBT-877 for th
Kraków, Poland-based Ryvu Therapeutics SA (formerly Selvita SA ) is to collaborate with Belgium biotech, Galapagos NV , on the discovery of small-molecule product candidates for the treatment of inf